| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/23/2026 | ±3.9% | -0.3% | over-priced |
| 04/23/2026 | ±4.5% | +1.9% | over-priced |
| 01/22/2026 | ±4.0% | -1.5% | over-priced |
| 11/19/2025 | ±2.8% | -0.7% | over-priced |
| 07/23/2025 | ±4.6% | -3.5% | over-priced |
| 04/23/2025 | ±3.3% | -0.1% | over-priced |
| 01/23/2025 | ±3.7% | -1.1% | over-priced |
| 11/19/2024 | ±2.6% | +0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $3.20 | $9.2B | $905M |
| Q2 FY2026 | $2.24 | $7.6B | $648M |
| Q1 FY2026 | $2.03 | $6.9B | $595M |
| Q4 FY2025 | — | $9.7B | $905M |
DHI (DHI) reports in 84 days, with the next report estimated for 01/19/2027. Across the last 8 reports, options priced an average ±3.7% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced DHI's earnings risk. Fundamentals into the print: EPS down 4.8% year-over-year, revenue up 0.0%. QuantLogix's live 5-factor engine currently reads DHI as a neutral at 47/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →